Gamma
oscillations
are
known
to
play
a
critical
role
in
memory
and
cognition
tasks.
The
quality
of
neural
activity
this
oscillatory
band
is
impaired
due
Alzheimer's
disease
(AD)
dementia.
Recently,
promoting
gamma
through
sensory
stimulation
has
shown
promising
therapeutic
results
reducing
structural
cognitive
symptoms
AD.
Further
analysis
on
the
effects
entrainment
brain's
could
help
better
understand
mechanisms
underlying
observed
improvements
optimize
protocols
for
achieving
outcome.
In
study,
we
investigate
40Hz
auditory
brain
synchronizing
frontoparietal
based
electroencephalogram
data
recorded
from
cohort
elderly
participants
with
complaints.
We
that
entrained
encompasses
entire
scalp
most
responsive
regions
frontal
parietal
lobes.
addition,
synchronized
synchronization
correlated
strength
entrainment.
other
word,
highly
sites
cortices
present
between
these
two
regions.
Long
distance
across
can
improve
functional
connectivity
disrupted
network-level
coordination
responsible
high-level
operations.
Neuropsychology Review,
Journal Year:
2023,
Volume and Issue:
34(1), P. 338 - 361
Published: March 6, 2023
Abstract
Despite
the
numerous
pharmacological
interventions
targeting
dementia,
no
disease-modifying
therapy
is
available,
and
prognosis
remains
unfavorable.
A
promising
perspective
involves
tackling
high-frequency
gamma-band
(>
30
Hz)
oscillations
involved
in
hippocampal-mediated
memory
processes,
which
are
impaired
from
early
stages
of
typical
Alzheimer’s
Disease
(AD).
Particularly,
positive
effects
entrainment
on
mouse
models
AD
have
prompted
researchers
to
translate
such
findings
into
humans
using
transcranial
alternating
current
stimulation
(tACS),
a
methodology
that
allows
endogenous
cortical
frequency-specific
manner.
This
systematic
review
examines
state-of-the-art
use
gamma-tACS
Mild
Cognitive
Impairment
(MCI)
dementia
patients
shed
light
its
feasibility,
therapeutic
impact,
clinical
effectiveness.
search
two
databases
yielded
499
records
resulting
10
included
studies
total
273
patients.
The
results
were
arranged
single-session
multi-session
protocols.
Most
demonstrated
cognitive
improvement
following
gamma-tACS,
some
showed
neuropathological
markers,
suggesting
feasibility
these
anyhow
far
strong
evidence
available
for
models.
Nonetheless,
small
number
their
wide
variability
terms
aims,
parameters,
measures,
make
it
difficult
draw
firm
conclusions.
We
discuss
methodological
limitations
studies,
proposing
possible
solutions
future
avenues
improve
research
dementia.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: April 11, 2024
Modulating
brain
oscillations
has
strong
therapeutic
potential.
Interventions
that
both
non-invasively
modulate
deep
structures
and
are
practical
for
chronic
daily
home
use
desirable
a
variety
of
applications.
Repetitive
audio-visual
stimulation,
or
sensory
flicker,
is
an
accessible
approach
modulates
hippocampus
in
mice,
but
its
effects
humans
poorly
defined.
We
therefore
quantified
the
neurophysiological
flicker
with
high
spatiotemporal
resolution
patients
focal
epilepsy
who
underwent
intracranial
seizure
monitoring.
In
this
interventional
trial
(NCT04188834)
cross-over
design,
subjects
different
frequencies
stimulation
same
recording
session
effect
exposure
on
local
field
potential
(LFP)
power
interictal
epileptiform
discharges
(IEDs)
as
primary
secondary
outcomes,
respectively.
Flicker
focally
modulated
potentials
expected
canonical
cortices
also
medial
temporal
lobe
prefrontal
cortex,
likely
via
resonance
stimulated
long-range
circuits.
Moreover,
decreased
discharges,
pathological
biomarker
degenerative
diseases,
most
strongly
regions
where
were
flicker-modulated,
especially
visual
cortex
lobe.
This
met
scientific
goal
now
closed.
Our
findings
reveal
how
multi-sensory
may
cortical
to
mitigate
activity
humans.
Frontiers in Aging Neuroscience,
Journal Year:
2022,
Volume and Issue:
14
Published: Dec. 15, 2022
Alzheimer's
disease
(AD)
is
characterized
by
reduced
fast
brain
oscillations
in
the
gamma
band
(γ,
>
30
Hz).
Several
animal
studies
show
that
inducing
through
(multi)sensory
stimulation
at
40
Hz
has
potential
to
impact
AD-related
cognitive
decline
and
neuropathological
processes,
including
amyloid
plaques
deposition,
neurofibrillary
tangles
formation,
neuronal
synaptic
loss.
Therefore
Gamma
Entrainment
Using
Sensory
(GENUS)
among
most
promising
approaches
for
AD
patients'
treatment.
This
review
summarizes
evidence
on
GENUS
effectiveness,
from
models
patients.
Despite
application
human
its
infancy,
available
findings
suggest
feasibility
treatment
of
AD.
We
discuss
such
results
light
parameter
improvement
possible
underlying
mechanisms.
finally
emphasize
need
further
research
development
as
a
disease-modifying
non-pharmacological
intervention.
Journal of Internal Medicine,
Journal Year:
2023,
Volume and Issue:
295(2), P. 146 - 170
Published: Dec. 19, 2023
Alzheimer's
disease
(AD)
is
the
most
common
type
of
neurodegenerative
and
a
health
challenge
with
major
social
economic
consequences.
In
this
review,
we
discuss
therapeutic
potential
gamma
stimulation
in
treating
AD
delve
into
possible
mechanisms
responsible
for
its
positive
effects.
Recent
studies
reveal
that
it
feasible
safe
to
induce
40
Hz
brain
activity
patients
through
range
multisensory
noninvasive
electrical
or
magnetic
methods.
Although
research
clinical
these
interventions
still
nascent
stages,
suggest
can
yield
beneficial
effects
on
function,
pathology,
cognitive
function
individuals
AD.
Specifically,
involving
light,
auditory,
vibrotactile
stimulation,
as
well
techniques
such
transcranial
alternating
current
stimulation.
The
precise
underpinning
are
not
yet
fully
elucidated,
but
preclinical
have
provided
relevant
insights.
We
evidence
related
both
neuronal
nonneuronal
may
be
involved,
touching
upon
relevance
interneurons,
neuropeptides,
specific
synaptic
translating
widespread
within
brain.
also
explore
roles
microglia,
astrocytes,
vasculature
mediating
function.
Lastly,
examine
upcoming
trials
contemplate
future
applications
management
disorders.
Trends in Pharmacological Sciences,
Journal Year:
2024,
Volume and Issue:
45(7), P. 586 - 601
Published: May 18, 2024
Alzheimer's
disease
(AD)
and
schizophrenia
(SCZ)
represent
two
major
neuropathological
conditions
with
a
high
burden.
Despite
their
distinct
etiologies,
patients
suffering
from
AD
or
SCZ
share
common
burden
of
disrupted
memory
functions
unattended
by
current
therapies.
Recent
preclinical
analyses
highlight
cell-type-specific
contributions
parvalbumin
interneurons
(PVIs),
particularly
the
plasticity
cellular
excitability,
towards
intact
neuronal
network
function
(cell-to-network
plasticity)
performance.
Here
we
argue
that
deficits
PVI
cell-to-network
may
underlie
in
SCZ,
explore
therapeutic
avenues:
targeting
PVI-specific
neuromodulation,
including
neuropeptides,
recruitment
synchrony
gamma
frequency
range
(40
Hz)
external
stimulation.
We
finally
propose
these
approaches
be
merged
under
consideration
recent
insights
into
human
brain
physiology.
Journal of Alzheimer s Disease Reports,
Journal Year:
2025,
Volume and Issue:
9
Published: Jan. 1, 2025
Studies
have
shown
that
gamma
(40
Hz)
audiovisual
stimulation
can
enhance
oscillations
and
improve
cognitive
functioning
in
patients
with
Alzheimer's
disease.
However,
despite
promising
long-term
results,
the
efficacy
of
short-duration
or
single-session
40
Hz
entrainment
humans
has
been
questioned
by
behavioral
studies
fail
to
find
observable
aftereffects,
for
two
possible
reasons:
1)
lack
validated
entrainment,
as
most
lacked
concurrent
electroencephalography
(EEG)
data
verify
neural
did
take
place,
2)
diverse
tests,
not
test
a
wide
range
factors.
This
study
aimed
increase
sensitivity
detecting
entrainment.
We
employed
mid-
post-stimulation
EEG
monitoring
ensure
worked,
comprehensive
battery
probes
perception,
attention,
working
memory,
memory.
Participants
received
30
min
synchronized
light
sound
stimulation,
followed
visual
perceptual
task,
attentional
network
change
detection
memory
picture
EEG.
observed
robust
during
but
no
significant
oscillation
after
improvements.
Despite
online
sensory
requires
consistent
exposure
induce
neurological
changes.
Future
research
should
determine
optimal
duration
frequency
maximize
its
therapeutic
potential.
Journal of Central Nervous System Disease,
Journal Year:
2025,
Volume and Issue:
17
Published: March 1, 2025
Cognitive
impairment
encompasses
a
spectrum
of
disorders
marked
by
acquired
deficits
in
cognitive
function,
potentially
leading
to
diminished
daily
functioning
and
work
capacity,
often
accompanied
psychiatric
behavioral
disturbances.
Alzheimer's
disease
(AD)
Post-stroke
(PSCI)
are
significant
causes
decline.
With
the
global
population
getting
older,
AD
PSCI
becoming
major
health
concerns,
underscoring
critical
necessity
for
successful
treatment
options.
In
recent
years,
various
non-invasive
biophysical
stimulation
techniques,
including
ultrasound,
light,
electric,
magnetic
stimulation,
have
been
developed
central
nervous
system
diseases.
Preliminary
clinical
studies
demonstrated
feasibility
safety
these
techniques.
This
review
discuss
impact
40
Hz
multisensory
on
cerebral
outcomes,
progression
both
animal
models
individuals
exhibiting
deficits,
such
as
PSCI.
Furthermore,
it
summarizes
potential
neural
pathways
involved
this
therapeutic
modality
synthesizing
evidence
from
variety
within
field.
Subsequently,
evaluates
existing
constraints
technique
underscores
advantages
therapy
with
goal
enhancing
management
care
Journal of Alzheimer s Disease,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 28, 2025
Background
Gamma
oscillation
modulation
has
emerged
as
a
potential
non-invasive
treatment
to
counteract
cognitive
impairment
in
Alzheimer's
disease
(AD)
and
mild
(MCI).
Non-invasive
brain
stimulation
techniques
like
transcranial
alternating
current
(tACS),
gamma
sensory
(GSS),
magnetic
(TMS)
show
promise
supporting
specific
functions.
Objective
To
review
evaluate
the
efficacy
of
benefiting
functions
among
individuals
with
AD
MCI.
Methods
A
systematic
was
conducted,
analyzing
studies
from
2015
2023
across
databases
such
PubMed,
Web
Science,
Scopus.
Inclusion
criteria
focused
on
involving
tACS,
GSS,
or
TMS
applied
older
adults
MCI
AD.
total
438
articles
were
screened,
which
10
met
eligibility
criteria.
Results
Findings
suggest
that
especially
targeting
precuneus
dorsolateral
prefrontal
cortex,
benefits
episodic
memory
performance.
GSS
also
showed
attention,
while
exhibited
inconsistent
but
promising
results
when
angular
gyrus.
However,
heterogeneity
study
designs
small
sample
sizes
limit
generalizability
these
outcomes.
Conclusions
offers
for
patients
MCI,
particularly
support.
Further
larger
samples
well-designed
protocols
are
needed
confirm
its
therapeutic
optimize
intervention
parameters.
Brain Research,
Journal Year:
2023,
Volume and Issue:
1815, P. 148457 - 148457
Published: June 12, 2023
This
review
aims
to
highlight
modern
neurostimulation
approaches
that
are
effectively
activating
the
hippocampus
and
enhancing
episodic
memory
performance.
The
is
a
brain
region
known
play
an
essential
role
in
processes.
However,
as
it
nestled
deep
within
brain,
has
been
challenging
target
for
traditional
approaches,
with
studies
reporting
inconsistent
effects.
Recent
suggest
more
than
half
of
electrical
current
from
non-invasive
transcranial
stimulation
(tES)
methods
may
be
attenuated
by
human
scalp,
skull,
cerebral
spinal
fluid.
Thus,
this
novel
showing
promise
alternative
routes
hippocampal
circuitry.
Early
evidence
suggests
temporal
interference,
closed-loop
individualized
protocols,
sensory
peripheral
nerve-targeted
tES
protocols
warrant
further
investigation.
These
each
provide
promising
a)
increasing
its
functional
connectiveness
key
regions,
b)
strengthening
synaptic
plasticity
mechanisms,
or
c)
neural
entrainment
specifically
between
theta
gamma
frequencies
these
regions.
Importantly,
three
mechanisms
hippocampus'
structural
integrity
negatively
impacted
throughout
progression
Alzheimer's
Disease,
deficits
likewise
evident
early
stages.
Consequently,
depending
on
validation
reviewed
here,
techniques
could
offer
significant
applied
therapeutic
value
patients
suffering
neurodegenerative
diseases
including
amnestic
Mild
Cognitive
Impairment
disease.